Liver Diseases  >>  evacetrapib (LY2484595)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
evacetrapib (LY2484595) / Eli Lilly
NCT01836185: A Study of Evacetrapib (LY2484595) in Participants With Hepatic (Liver) Impairment

Completed
1
32
US
Evacetrapib, LY2484595
Eli Lilly and Company
Hepatic Insufficiency
10/13
10/13

Download Options